Top 5 Players in Human Primary Cells Market
.png)
Published: July 2026
Human primary cells are cells taken directly from human tissue and grown in the laboratory for research. Because they are not extensively altered or immortalized, they usually preserve many of the structural and functional features of the original tissue, which makes them a more realistic model of normal human biology than permanent cell lines.
These cells are widely used in biomedical research to study cell behavior, disease mechanisms, drug responses, and tissue-specific functions. These cells closely mimic human physiology, making them highly valuable for developing reliable, predictive preclinical models. Owing to the advantages offered by human primary cells and growing importance in drug discovery, toxicology testing, and advanced biological research, the market is expanding steadily. Further, the increased focus on personalized medicine and CAR-T cell therapy is also propelling the demand for high-quality primary cells across research and clinical applications. In addition, rising investment in regenerative medicine and biotechnology research is encouraging wider adoption of these cells in both academic and commercial settings.
Roots Analysis has conducted an exhaustive study on featuring the current landscape and future opportunity for the companies engaged in the primary cells domain. In this article, we have highlighted companies offering human primary cells that are likely to shape the evolution of biopharmaceutical sector during the forecast period.
Top Five Companies Offering Human Primary Cells
- Lonza
- Applied Biological Materials
- ScienCell Research Laboratories
- Cell Applications
- Lab4Paws
Want to explore more about Primary Cells Market?
Discover Below the Details on Key 5 Companies Offering Human Primary Cells
Let us dive deep into the details of the key 5 companies offering human primary cells. It is essential to note that the selection of these key players can differ substantially according to the defined criteria.
1. Lonza
Company Overview
Lonza is a Swiss drug manufacturing company, which is engaged in offering integrated solutions for research and development, and manufacturing of biologics to various industry, as well as non-industry stakeholders in the pharmaceutical, biotech and nutraceutical domain. Additionally, the company follows a B2B business model by extending its services to manufacturers of consumer health products, distributors, formulators and other service-based companies.
 |
Company Name | Year of Establishment | Headquarters | Number of Employees |
| Lonza | 1987 | Switzerland | 10,000+ |
Recent Developments
In April 2026, the firm participated in the Cell & Gene Meeting, which was held in Arizona, US. Notably, this conference was focused on advancing research and patient access, emphasizing manufacturing and standardization and commercialization strategies. Further, in March 2026, the firm has launched a Media Development Lab at its Singapore site aimed to optimize cell culture media formulations for bioprocessing customers, facilitating a smooth transition to GMP manufacturing.
To know more about the recent initiatives of Lonza and other companies offering human primary cells, access full report.
2. Applied Biological Materials
Company Overview
Applied Biological Materials is a biotechnology company focused on the development of innovation products for life sciences research and drug development. The company operates through two facilities, spanning across Canada (research and development center, and global logistics) and China. Further, the company claims to have achieved consistent recognition as one of the top 25 fastest-growing companies in British Columbia, Canada with 30% average annual growth rate since its incorporation.
 |
Company Name | Year of Establishment | Headquarters | Number of Employees |
| Applied Biological Materials | 2004 | Canada | 11 to 50 |
Recent Developments
In April 2026, the firm participated in the American Association for Cancer Research conference, which was held in San Diego, US. Notably, the conference features more than 100 scientific sessions, close to 7,400 abstract presentations and extensive industry networking opportunities.
To know more about the recent initiatives of Applied Biological Materials and other companies offering human primary cells, access full report.
3. ScienCell Research Laboratories
Company Overview
ScienCell Research Laboratories specializes in the research, development and supply of high-quality human and animal primary cells, stem cells, and supporting cell culture media, reagents, and supplements. It is worth highlighting that the company claims to be the first to introduce frozen human primary neurons and a unique global supplier of primary Schwann cells. Additionally, the company supports biomedical research worldwide with products, such as 3D cell culture systems, gene expression analysis tools, and cell-derived DNA, RNA, and proteins.
 |
Company Name | Year of Establishment | Headquarters | Number of Employees |
| ScienCell Research Laboratories | 1999 | US | 11 to 50 |
Recent Developments
In April 2026, the firm participated in the American Association for Cancer Research conference, which was held in San Diego, US. Notably, the conference features more than 100 scientific sessions, close to 7,400 abstract presentations and extensive industry networking opportunities.
To know more about the recent initiatives of ScienCell Research Laboratories and other companies offering human primary cells, access full report.
4. Cell Applications
Company Overview
Cell Applications is a US based company, which is recognized for its extensive catalog of over 100 different human and animal cell types, including specialized lines, such as endothelial, epithelial, and smooth muscle cells. The company offers diverse primary cells isolated from various tissues and species, offering researchers access to nearly 900 distinct cell‑ordering configurations used in universities, non‑profit institutes and commercial customers in pharma, biotech and consumer‑health sectors.
 |
Company Name | Year of Establishment | Headquarters | Number of Employees |
| Cell Applications | 1994 | US | 11 to 50 |
Recent Developments
In December 2025, the company premiered a video on independent peer-reviewed article in Histochemistry and Cell Biology timed for American Society for Cell Biology CellBio conference, which was held at Pennsylvania, US.
To know more about the recent initiatives of Cell Applications and other companies offering human primary cells, access full report.
5. Lab4Paws
Company Overview
Lab4Paws is a Germany-based company focused on the development of innovative research tools for veterinary research and development. The company specializes in ethically sourced biospecimens (including serum, plasma, urine, swabs and other biofluids) and dissociated primary and tumor cells from various animal tissues. By collaborating with veterinary clinics across Europe to obtain clinically relevant samples, the company positions itself as a niche supplier of more than 650 animal‑specific products and associated research services.
 |
Company Name | Year of Establishment | Headquarters | Number of Employees |
| Lab4Paws | 2023 | Germany | 2 to 10 |
Recent Developments
In April 2026, the firm participated in the Germany Biotechnology Days conference, which was held in Leipzig, Germany. Notably, the conference aimed to foster innovation and partnerships to build a sustainable, competitive and innovative biotechnology ecosystem in Europe. Further, in the same time, The firm participated in the Analytica trade fair, which was held in Munich, Germany. Notably, the trade fair focused on digital transformation, such as artificial intelligence, machine learning, automated workflows along with sustainable laboratory practices.
To know more about the recent initiatives of Lab4Paws and other companies offering human primary cells, access full report.
What About Other Companies Developing Human Primary Cells Around the World?
The above article features the key five companies offering human primary cells selected from a pool of around 65 companies that we have compiled. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at .
Browse our full report on Primary Cells Market:
https://www.rootsanalysis.com/reports/primary-cells-market.html
Sources:
- https://bioscience.lonza.com/lonza-launches-media-development-lab-in-singapore-for-cell-culture-media-optimization
- https://meetingonthemed.com/
- https://www.linkedin.com/posts/applied-biological-materials_were-excited-to-be-attending-aacr-this-activity-7444813436083081217-a28d/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAD2n0ZYB6fOABLSZooT6-y3bJNJ_IsnvR00
- https://www.abmgood.com/summer-symposium-bbq-2025
- https://www.linkedin.com/posts/biomex-gmbh_biomex-sciencell-provitro-activity-7259478320738713600-uNCo?utm_source=share&utm_medium=member_desktop&rcm=ACoAAD2n0ZYB6fOABLSZooT6-y3bJNJ_IsnvR00
- https://provitro.com/sciencell-products/
- https://cellapplications.com/blog/
- https://www.businesswire.com/news/home/20241113340535/en/Celebrating-30-Years-of-Innovation-Cell-Applications-Unveils-Groundbreaking-Brown-Fat-Cells
- https://www.linkedin.com/posts/davide-confalonieri-phd_deutsche-biotechnologietage-2026-started-activity-7452298592976822272-Tnhs?utm_source=share&utm_medium=member_desktop&rcm=ACoAAD2n0ZYB6fOABLSZooT6-y3bJNJ_IsnvR00
- https://www.linkedin.com/posts/davide-confalonieri-phd_analytica2026-activity-7442657789430243328-T8SE/?utm_source=share&utm_medium=member_desktop&rcm=ACoAAD2n0ZYB6fOABLSZooT6-y3bJNJ_IsnvR00